• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Adipose tissue-skeletal muscle crosstalk: are endocannabinoids an unwanted caller?

作者信息

Watt M J

机构信息

Department of Physiology, Monash University, Building 13F, Clayton, VIC, 3800, Australia.

出版信息

Diabetologia. 2009 Apr;52(4):571-3. doi: 10.1007/s00125-009-1287-x. Epub 2009 Feb 10.

DOI:10.1007/s00125-009-1287-x
PMID:19205657
Abstract
摘要

相似文献

1
Adipose tissue-skeletal muscle crosstalk: are endocannabinoids an unwanted caller?
Diabetologia. 2009 Apr;52(4):571-3. doi: 10.1007/s00125-009-1287-x. Epub 2009 Feb 10.
2
Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle.人类骨骼肌细胞中的1型大麻素受体参与脂肪与肌肉之间的负性相互作用。
Diabetologia. 2009 Apr;52(4):664-74. doi: 10.1007/s00125-008-1240-4. Epub 2008 Dec 17.
3
Endocannabinoids, adipose tissue and lipid metabolism.内源性大麻素、脂肪组织与脂质代谢
J Neuroendocrinol. 2008 May;20 Suppl 1:124-9. doi: 10.1111/j.1365-2826.2008.01690.x.
4
Minireview: Endocannabinoids and their receptors as targets for obesity therapy.综述：内源性大麻素及其受体作为肥胖治疗的靶点
Endocrinology. 2009 Jun;150(6):2531-6. doi: 10.1210/en.2009-0046. Epub 2009 Apr 16.
5
[Adiponectin: from adipocyte to skeletal muscle].[脂联素：从脂肪细胞到骨骼肌]
Ann Endocrinol (Paris). 2004 Feb;65(1 Suppl):S36-43. doi: 10.1016/s0003-4266(04)95999-9.
6
New fat and new neurons: endocannabinoids control neurogenesis in obesity (Commentary on Rivera et al.).新脂肪与新神经元：内源性大麻素调控肥胖中的神经发生（对里维拉等人研究的评论）
Eur J Neurosci. 2011 May;33(9):1575-6. doi: 10.1111/j.1460-9568.2011.07684.x.
7
[Endocannabinoid system and energy metabolism: physiology and pathophysiology].[内源性大麻素系统与能量代谢：生理学与病理生理学]
G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):74S-82S.
8
Cannabinoid receptors and endocannabinoids: evidence for new players.大麻素受体与内源性大麻素：新角色的证据
AAPS J. 2006 Apr 28;8(2):E298-306. doi: 10.1007/BF02854900.
9
Novel Mediators of Adipose Tissue and Muscle Crosstalk.脂肪组织和肌肉相互作用的新介质。
Curr Obes Rep. 2015 Dec;4(4):411-7. doi: 10.1007/s13679-015-0174-7.
10
The endocannabinoid system in obesity and type 2 diabetes.肥胖症和2型糖尿病中的内源性大麻素系统。
Diabetologia. 2008 Aug;51(8):1356-67. doi: 10.1007/s00125-008-1048-2. Epub 2008 Jun 18.

本文引用的文献

1
Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle.人类骨骼肌细胞中的1型大麻素受体参与脂肪与肌肉之间的负性相互作用。
Diabetologia. 2009 Apr;52(4):664-74. doi: 10.1007/s00125-008-1240-4. Epub 2008 Dec 17.
2
Rimonabant ameliorates insulin resistance via both adiponectin-dependent and adiponectin-independent pathways.利莫那班通过脂联素依赖和脂联素非依赖途径改善胰岛素抵抗。
J Biol Chem. 2009 Jan 16;284(3):1803-12. doi: 10.1074/jbc.M807120200. Epub 2008 Nov 13.
3
The endocannabinoid system in obesity and type 2 diabetes.
肥胖症和2型糖尿病中的内源性大麻素系统。
Diabetologia. 2008 Aug;51(8):1356-67. doi: 10.1007/s00125-008-1048-2. Epub 2008 Jun 18.
4
The CB1 endocannabinoid system modulates adipocyte insulin sensitivity.CB1内源性大麻素系统调节脂肪细胞的胰岛素敏感性。
Obesity (Silver Spring). 2008 Aug;16(8):1727-34. doi: 10.1038/oby.2008.309. Epub 2008 Jun 12.
5
Adipose tissue infiltration in skeletal muscle: age patterns and association with diabetes among men of African ancestry.骨骼肌中的脂肪组织浸润：非洲裔男性的年龄模式及其与糖尿病的关联。
Am J Clin Nutr. 2008 Jun;87(6):1590-5. doi: 10.1093/ajcn/87.6.1590.
6
Cannabinoid type 1 receptor: another arrow in the adipocytes' bow.大麻素1型受体：脂肪细胞的又一利器。
J Neuroendocrinol. 2008 May;20 Suppl 1:130-8. doi: 10.1111/j.1365-2826.2008.01682.x.
7
Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.脂肪组织的致病潜力以及脂肪细胞肥大和内脏脂肪增多的代谢后果。
Expert Rev Cardiovasc Ther. 2008 Mar;6(3):343-68. doi: 10.1586/14779072.6.3.343.
8
Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program.利莫那班改善超重/肥胖患者多种心血管代谢危险因素的疗效和安全性：来自肥胖症利莫那班（RIO）项目的1年汇总数据。
Diabetes Care. 2008 Feb;31 Suppl 2:S229-40. doi: 10.2337/dc08-s258.
9
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials.减肥药物利莫那班的疗效与安全性：随机试验的荟萃分析
Lancet. 2007 Nov 17;370(9600):1706-13. doi: 10.1016/S0140-6736(07)61721-8.
10
CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health.CB1受体：调节能量平衡、新陈代谢和心血管健康的中枢及外周机制的新证据。
Diabetes Metab Res Rev. 2007 Oct;23(7):507-17. doi: 10.1002/dmrr.764.